Jaume Pons – Biography
Last update: April 21, 2026Executive profile
Jaume was Senior Vice President and Chief Scientific Officer at Pfizer, Inc, and President and Chief Scientific Officer at ALX Oncology. Jaume Pons joined Tallac Therapeutics in 2023.
Jaume Pons is currentlyDirector at Tallac Therapeutics - View - Tallac Therapeutics org chart
Create your alert
to follow the career of Jaume Pons.
Education
Jaume Pons has a Postdoc in Protein Engineering from University of California, Berkeley.
They have also studied at University of California, Berkeley :
Find more alumni from University of California, Berkeley
More about Jaume Pons
Selected links
Do you need to know more about Jaume Pons? More results.
Participate
Social media
- Jaume Pons on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Jaume Pons
The colleagues of Jaume Pons
Company Colleagues
- At Tallac Therapeutics, Jaume Pons has 14 colleagues including Hong Wan (CEO & President), Isaac Cheng (Director)…
Industry Colleagues
- In the Biotechnology industry, Jaume Pons has 35,763 colleagues in 2,407 companies located in 42 countries. 16,856 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Get in Touch
Here are a few tips for establishing great contacts.
